Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 2, 2004
and Orlando, FL (November 2, 2004)-- Boston Scientific Corporation (NYSE: BSX) today announced results supporting the efficacy of the Enteryx Procedure in relieving the symptoms of...
-
Nov 2, 2004
and Orlando, FL (November 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced two-year follow-up data from its ongoing Enteryx Procedure clinical trial for the treatment of...
-
Nov 1, 2004
Innovative uterine fibroid embolization (UFE) procedure is a less-invasive treatment option for fibroids.
-
Oct 28, 2004
Full line of mid-urethral sling products for the treatment of female stress urinary incontinence.
-
Oct 27, 2004
ARRIVE 2 registry program plans to enroll 5,000 patients at approximately 60 centers in the United States.
-
Oct 26, 2004
Repurchased shares will be made available for issuance under the Company's equity incentive plans and for general corporate purposes.
-
Oct 19, 2004
“This quarter was one of the best performances in our history," said Jim Tobin, President and CEO.
-
Oct 13, 2004
Company will launch the product immediately.
-
Oct 6, 2004
A live webcast and replay of the Tuesday, October 19 conference call will be available.
-
Oct 1, 2004
Registries studied more than 7,000 patients at 236 sites around the globe; results consistent with controlled TAXUS studies.